홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Imidazole → 4-((alphaS)-alpha-((2R,5R)-2,5-dimethyl-4-propyl-1-piperazinyl)-3-(tert-butyldimethylsilyloxy)benzyl)-N,N-diethylbenzamide

HRID 2393305
노트
인쇄 미리보기

반응식

HRID 2393305 반응식
[CH2:1]([N:4]1[C@H:9]([CH3:10])[CH2:8][N:7]([C@@H:11]([C:19]2[CH:31]=[CH:30][C:22]([C:23]([N:25]([CH2:28][CH3:29])[CH2:26][CH3:27])=[O:24])=[CH:21][CH:20]=2)[C:12]2[CH:17]=[CH:16][CH:15]=[C:14]([OH:18])[CH:13]=2)[C@H:6]([CH3:32])[CH2:5]1)[CH:2]=[CH2:3].C1(O)C=CC=CC=1.[C:40]([Si:44](Cl)([CH3:46])[CH3:45])([CH3:43])([CH3:42])[CH3:41].N1C=CN=C1>C1(C)C=CC=CC=1.C(#N)C.O>[CH3:32][C@@H:6]1[CH2:5][N:4]([CH2:1][CH2:2][CH3:3])[C@H:9]([CH3:10])[CH2:8][N:7]1[C@@H:11]([C:19]1[CH:20]=[CH:21][C:22]([C:23]([N:25]([CH2:26][CH3:27])[CH2:28][CH3:29])=[O:24])=[CH:30][CH:31]=1)[C:12]1[CH:17]=[CH:16][CH:15]=[C:14]([O:18][Si:44]([C:40]([CH3:43])([CH3:42])[CH3:41])([CH3:46])[CH3:45])[CH:13]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 795ImidazoleHCID 996PhenolHCID 28928tert-Butyldimethylsilyl chlorideHCID 10238234HCID 10238234, 화합물

생성물 1

HCID 186650764-((alphaS)-alpha-((2R,5R)-2,5-dimethyl-4-propyl-1-piperazinyl)-3-(tert-butyldimethylsilyloxy)benzyl)-N,N-diethylbenzamide수율 33.5%

시약·촉매·용매 3

HCID 962
Water
용매
HCID 1140Toluene용매
HCID 6342Acetonitrile용매

실험 절차

(-)-4-((αS)-α-((2R,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N,N-diethylbenzamide (0.200 g, 0.46 mmol, Example 2) was dissolved in toluene (10 mL) and stirred for 4 hours under a hydrogen atmosphere. The solution was filtered through celite to give 0.182 g of crude product. The phenol was reprotected as follows to improve chromatographic resolution. A mixture of crude product (0.18 g), tert-butylchlorodimethylsilane (0.93 g), and imidazole (0.070 g) in 10 mL of acetonitrile was stirred overnight at room temperature. The reaction solution was poured into 100 mL of water and extracted with two 50 mL portions of dichloromethane. The combined extracts were dried over sodium sulfate and the solvent removed. The residue was purified on a column of silica gel with ethanol (0-4%) in dichloromethane to give 0.085 g of 4-((αS)-α-((2R,5R)-2,5-dimethyl-4-propyl-1-piperazinyl)-3-(tert-butyldimethylsilyloxy)benzyl)-N,N-diethylbenzamide as a light-brown solid.

후처리

  1. filtrationThe solution was filtered through celite
  2. customto give 0.182 g of crude product
  3. stirringwas stirred overnight at room temperature
  4. extractionextracted with two 50 mL portions of dichloromethane
  5. dry with materialThe combined extracts were dried over sodium sulfate
  6. customthe solvent removed
  7. customThe residue was purified on a column of silica gel with ethanol (0-4%) in dichloromethane

출처 및 근거

ORD 기록
ord-7c751b8d6c7f4b33b72d357b0c6276e9
출처 데이터셋
uspto-grants-1998_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05807858

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트